BB Biotech

BB Biotech is owned by Bellevue Group.

Bellevue Group has a direct presence in 3 countries.

Bellevue Group has 4 subsidiaries including BB Biotech, BB Pureos Bioventures and Bellevue Healthcare Trust.

They are in:

• Financial Services40%
• Holding40%
• Other20%

View the org chart displaying its 15 main executives

Most searched biographies at BB Biotech

• Daniel Koller, Chief Executive Officer
• Clive Meanwell, Vice Chairman of the Board of Directors
• Erich Hunziker, Chairman of the Board of Directors

Create an alert
to follow the executive moves at BB Biotech.

Bellevue Group has 1,229 competitors including Berkshire Hathaway (United States (USA)), Amundi (France) and Apollo Global Management (United States (USA)).

Popular M&A news in Holding

• Oxford Science Enterprises has just announced a $250 Million fundraising. (posted on July 28 2022).
• Sanctuary Wealth has just announced a $125 Million fundraising. (posted on July 22 2022).
• Bloom Group has just announced a $300 Million fundraising. (posted on June 2 2022).

Popular contacts in Holding

• Sami Mnaymneh - Co-Founder and Co-Chief Executive Officer at H.I.G. Capital
• Barry Siadat - Co-Founder and Managing Director at SK Capital
• Elliott Aintabi - Chairman of the Board and Chief Executive Officer at Jesta Group

Learn more about the Holding industry >

Press releases by BB Biotech

• First signs of increased M&A activity due to attractive valuations
• BB Biotech AG publishes its interim report
• BB BIOTECH - Disclaimer
• BB BIOTECH - Disclaimer
• BB BIOTECH - Disclaimer
• BB BIOTECH - Disclaimer
• BB BIOTECH - Disclaimer
• BB BIOTECH - Disclaimer
• BB BIOTECH - Disclaimer
• BB BIOTECH - Disclaimer
• View more press releases Close

Social media about BB Biotech

• BB Biotech on Wikipedia, Google News & Yahoo Finance
• BB Biotech on LinkedIn, Twitter & YouTube

Contact by email its executives including Clive Meanwell

Call BB Biotech at +41 52...

View the org chart

Register to receive your alert

Report an error